Cross Atlantic Partners

Labcyte Inc. is a laboratory instrumentation company based in San Jose, California, specializing in acoustic droplet ejection (ADE) technology for life sciences applications. Established in 2000, Labcyte develops innovative solutions for drug discovery, genomic research, cancer research, and personalized medicine through its precise liquid dispensing technology. This technology utilizes focused acoustic energy to eject nanoliter-scale droplets of fluid, allowing for high accuracy and reduced consumption of materials. Labcyte's product offerings include automation systems, laboratory workstations, and control software aimed at enhancing research efficiency and data reliability. The company operates as a subsidiary of Beckman Coulter, Inc. and maintains additional offices across multiple countries, including Canada, the United Kingdom, and Japan.

QuesCom S.A. designs and manufactures Internet telecommunication systems. The company provides business communication management portal, GSM gateway, SIM servers, and mobile call servers. It partners with Aastra, Alcatel, Avaya Inc. & Cisco. QuesCom S.A. was founded in 1999 and is headquartered in Sophia Antipolis, France.

Sapphire Digital is a health care technology company that provides solutions aimed at reducing the cost of care for consumers, employers, and health plans. The company offers an engagement and shopping platform that includes tools such as CareSelect for finding care and understanding costs, SmartShopper, which incentivizes employees to choose high-quality, cost-effective care, and MEG, providing quality scores for surgeons and facilities to aid in decision-making. Sapphire Digital also features Sapphire 360, which assists health plans in negotiating competitive rates and managing medical expenses through data and analytics. Founded in 2007 and based in Lyndhurst, New Jersey, with additional offices in New York, Oklahoma, and New Hampshire, the company serves over 280 million individuals annually, helping them make informed health care choices. Formerly known as Vitals, the company rebranded to Sapphire Digital in February 2019.

Mobile Digital Media offers software that runs games and other applications on mobile devices.

Filao publishes, develops, and distributes java based mobile games and java mobile gaming technologies for mass market mobile devices. It specializes in embedded java technologies, wireless games, and entertainment applications. The company serves mobile operators and PDA and handset manufacturers. It distributes its products through shipped, over the air, online, and specialized retail outlets. The company was founded in 2000 as InfraWorlds SA and changed its name to Filao in 2005. Filao is based in Paris, France. As of May 10, 2007, Filao is a subsidiary of Zenops SA.

Labcyte Inc. is a laboratory instrumentation company based in San Jose, California, specializing in acoustic droplet ejection (ADE) technology for life sciences applications. Established in 2000, Labcyte develops innovative solutions for drug discovery, genomic research, cancer research, and personalized medicine through its precise liquid dispensing technology. This technology utilizes focused acoustic energy to eject nanoliter-scale droplets of fluid, allowing for high accuracy and reduced consumption of materials. Labcyte's product offerings include automation systems, laboratory workstations, and control software aimed at enhancing research efficiency and data reliability. The company operates as a subsidiary of Beckman Coulter, Inc. and maintains additional offices across multiple countries, including Canada, the United Kingdom, and Japan.

GQ Life Sciences, Inc. is a global life science information and search company. Formerly known as GenomeQuest, Inc., they changed their name in September of 2015 to highlight the fact that the product GenomeQuest has become a well-known brand within the industry. GQ Life Sciences is proud to offer its second major product, LifeQuest, alongside its flagship GenomeQuest software.

Medivance, Inc. specializes in the development, manufacturing, and sale of temperature management products for hospitals globally. The company's primary product, the Arctic Sun Temperature Management System, is a non-invasive device that assists clinicians in monitoring and regulating patient temperature. In addition to its product offerings, Medivance provides clinical training in Targeted Temperature Management to ensure effective use of its systems. Founded in 1998, Medivance is headquartered in Louisville, Colorado, with a European office located in Den Hague, the Netherlands. Since November 2011, it has operated as a subsidiary of Bard Medical, Inc.

Filao publishes, develops, and distributes java based mobile games and java mobile gaming technologies for mass market mobile devices. It specializes in embedded java technologies, wireless games, and entertainment applications. The company serves mobile operators and PDA and handset manufacturers. It distributes its products through shipped, over the air, online, and specialized retail outlets. The company was founded in 2000 as InfraWorlds SA and changed its name to Filao in 2005. Filao is based in Paris, France. As of May 10, 2007, Filao is a subsidiary of Zenops SA.

Confluent Surgical develops products to address the need for surgical sealing and post-surgical adhesion prevention applications.The company provides DuraSeal, an adjunct to sutured dural repair during cranial surgeries to provide watertight closure. The company was founded in 1998 and is headquartered in Waltham, Massachusetts.

Acorda Therapeutics is a biopharmaceutical company focused on developing and commercializing therapies for neurological disorders in the United States and internationally. The company’s primary product, Ampyra (dalfampridine), is an oral medication approved to enhance walking in patients with multiple sclerosis. Additionally, Acorda markets Inbrija, an inhalation powder for the treatment of OFF periods in individuals with Parkinson's disease. The company's pipeline includes rHIgM22, which has completed Phase I trials for multiple sclerosis, and Cimaglermin alfa, currently in Phase Ib trials for heart failure. Acorda has established a collaboration with Biogen for the development and commercialization of Ampyra. Founded in 1995 and based in Ardsley, New York, Acorda Therapeutics aims to improve the quality of life for those affected by neurological conditions.

Confluent Surgical develops products to address the need for surgical sealing and post-surgical adhesion prevention applications.The company provides DuraSeal, an adjunct to sutured dural repair during cranial surgeries to provide watertight closure. The company was founded in 1998 and is headquartered in Waltham, Massachusetts.

Medivance, Inc. specializes in the development, manufacturing, and sale of temperature management products for hospitals globally. The company's primary product, the Arctic Sun Temperature Management System, is a non-invasive device that assists clinicians in monitoring and regulating patient temperature. In addition to its product offerings, Medivance provides clinical training in Targeted Temperature Management to ensure effective use of its systems. Founded in 1998, Medivance is headquartered in Louisville, Colorado, with a European office located in Den Hague, the Netherlands. Since November 2011, it has operated as a subsidiary of Bard Medical, Inc.